Valuation: Celltrion, Inc.

Market Cap 42,768B 31.91B 27.49B 26.03B 23.59B 44.26B 3,048B 44.49B 309B 119B 1,551B 120B 117B 4,900B P/E 2026 *
27x
P/E 2027 * 23.1x
Enterprise Value 44.98B 33.56M 28.91M 27.38M 24.81M 46.55M 3.21B 46.79M 325M 125M 1.63B 126M 123M 5.15B EV / Sales 2026 *
8.15x
EV / Sales 2027 * 6.96x
Free-Float
60.59%
Yield 2026 *
0.42%
Yield 2027 * 0.47%
1 day-1.44%
1 week-5.26%
Current month-5.66%
1 month-11.78%
3 months+3.01%
6 months-8.95%
Current year+3.38%
1 week 176,500
Extreme 176500
188,800
1 month 176,500
Extreme 176500
202,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-5.26%+8.97%+39.76% 31.91B
+0.83%-4.50%-2.16%+9.42% 45.48B
-1.15%-2.36%+338.15%+521.90% 43.68B
+2.05%+2.60%+43.00%+24.88% 43.09B
+1.76%+0.47%+6.27%+77.89% 39.4B
-0.34%-2.56% - - 17.31B
+1.83%+0.83%+20.02%+112.76% 16.4B
+2.38%+1.09%+14.74%+31.31% 14.24B
-0.10%-1.28%+82.05%+33.40% 13.28B
+1.76%+8.74%+1.01%-34.23% 13.06B
Average +0.69%-2.61%+56.90%+90.79% 27.78B
Weighted average by Cap. +0.60%-3.20%+71.77%+118.69%

Financials

2026 *2027 *
Net sales 5,518B 4.12B 3.55B 3.36B 3.04B 5.71B 393B 5.74B 39.89B 15.34B 200B 15.46B 15.12B 632B 6,337B 4.73B 4.07B 3.86B 3.5B 6.56B 452B 6.59B 45.81B 17.62B 230B 17.76B 17.37B 726B
Net income 1,536B 1.15B 987M 935M 847M 1.59B 109B 1.6B 11.1B 4.27B 55.68B 4.3B 4.21B 176B 1,785B 1.33B 1.15B 1.09B 985M 1.85B 127B 1.86B 12.9B 4.96B 64.72B 5B 4.89B 204B
Net Debt 2,215B 1.65B 1.42B 1.35B 1.22B 2.29B 158B 2.3B 16.01B 6.16B 80.3B 6.2B 6.07B 254B 1,355B 1.01B 871M 825M 747M 1.4B 96.57B 1.41B 9.79B 3.77B 49.13B 3.8B 3.71B 155B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-14 ₩178,800.00 +0.34% 380,491
26-09-11 ₩178,200.00 -1.44% 564,770
26-09-10 ₩180,800.00 -1.26% 742,053
26-09-09 ₩183,100.00 0.00% 372,393
26-09-08 ₩183,100.00 -1.72% 482,451
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
178,200.00KRW
Average target price
268,232.21KRW
Spread / Average Target
+50.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!